17q21.31 locus regulates Parkinson’s disease relevant pathways through <i>KANSL1</i> activity
Amy R. Hicks(National Hospital for Neurology and Neurosurgery), Mina Ryten(Guy's Hospital), Caitlin A. Loh(National Hospital for Neurology and Neurosurgery), John Hardy(UK Dementia Research Institute), Guillermo Rocamora Perez(Great Ormond Street Hospital), Regina H. Reynolds(Great Ormond Street Hospital), Kylie Montgomery(New England Biolabs (United States)), Hélène Plun‐Favreau(National Hospital for Neurology and Neurosurgery), Sarah J. Marzi(King's College London), Aine Fairbrother-Browne(European Bioinformatics Institute), Benjamin O’Callaghan(National Hospital for Neurology and Neurosurgery), Melissa Grant‐Peters(Great Ormond Street Hospital), Zane Jaunmuktane(King's College London), Katie Lunnon(Van Andel Institute), Emil K. Gustavsson(University of British Columbia), Huw R. Morris(University College London), Raquel Real(Neurosciences Institute), Maria Tsalenchuk(King's College London), Jonathan Brenton(Great Ormond Street Hospital)
Cited by 0
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k